Identification | Back Directory | [Name]
Selaginellin | [CAS]
941269-84-7 | [Synonyms]
Selaginellin 2,5-Cyclohexadien-1-one, 4-[[4'-hydroxy-4-(hydroxymethyl)-3-[2-(4-hydroxyphenyl)ethynyl][1,1'-biphenyl]-2-yl](4-hydroxyphenyl)methylene]- | [Molecular Formula]
C34H24O5 | [MOL File]
941269-84-7.mol | [Molecular Weight]
512.55 |
Hazard Information | Back Directory | [Uses]
Selaginellin is an inhibitor of Reactive Oxygen Species and an activator of SIRT1. Selaginellin protects endothelial cells against homocysteine-induced senescence by inhibitng reactive oxygen species and upregulating SIRT1 gene expression[1]. | [References]
[1] Wang CJ, et al. Effects of selaginellin on homocysteine-induced senescence in human umbilical vein endothelial cells. J Cardiovasc Pharmacol. 2010 Jun;55(6):560-6. DOI:10.1097/FJC.0b013e3181d9f478 |
|
Company Name: |
Biorbyt Ltd.
|
Tel: |
+44 (0)1223 859 353 |
Website: |
www.biorbyt.com |
|